Screener

R&D

Name: Tarsus Pharmaceuticals, Inc. R&D by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Tarsus Pharmaceuticals, Inc.·Business Segments·1 segment·Rolls up to R&D

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Business Segments	$14.41M	$15.59M	$16.28M	$18.04M	$22.35M	$31.01M
Total	$14.41M	$15.59M	$16.28M	$18.04M	$22.35M	$31.01M

Business SegmentsView metric